Analystreport

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) was upgraded by analysts at William Blair to a "strong-buy" rating.

Xenon Pharmaceuticals Inc. - Common Shares  (XENE) 
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com